Orthoproducts
Orthoproducts was an established provider (45% global market share) of high-quality, medical-grade ultra-high molecular weight polyethylene (UHMWPE) for hip, knee and spinal orthopaedic implants.
Harwood acquired the company through a divestment from a listed company and exited via a trade sale to a large medical device manufacturing and design company.
![Orthoproducts logo](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/ORTHOPRODUCTS-LOGO-RGB-1.webp)
Fund
Fund 2
Investment date
April 2008
Deal type
Buyout
Sector
Health Services
Exit date
October 2013
Exit type
Trade sale
![Science rooms](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/dentist-office-1.webp)
![Hip joint](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/Hip-Joint-2.webp)
![Science scan](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/09/6DAG8626-1.webp)
![City and trees](https://d3aips7aqii8y4.cloudfront.net/app/uploads/2022/11/harwood_aerial_cropped.png)